John B. Robbins
National Institute of Child Health and Human Development
National Institutes of Health
9000 Rockville Pike
Bethesda
USA
Name/email consistency: high
- Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates. Robbins, J.B., Kubler-Kielb, J., Vinogradov, E., Mocca, C., Pozsgay, V., Shiloach, J., Schneerson, R. Proc. Natl. Acad. Sci. U.S.A. (2009)
- Pertussis vaccine: a critique. Robbins, J.B., Schneerson, R., Keith, J.M., Miller, M.A., Kubler-Kielb, J., Trollfors, B. Pediatr. Infect. Dis. J. (2009)
- The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. Robbins, J.B., Schneerson, R., Keith, J.M., Shiloach, J., Miller, M., Trollors, B. Vaccine (2007)
- The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins. Robbins, J.B., Schneerson, R., Trollfors, B., Sato, H., Sato, Y., Rappuoli, R., Keith, J.M. J. Infect. Dis. (2005)
- Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. Robbins, J.B., Schneerson, R., Horwith, G., Naso, R., Fattom, A. Am. Heart J. (2004)
- Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Robbins, J.B., Schneerson, R., Gotschlich, E.C., Mohammed, I., Nasidi, A., Chippaux, J.P., Bernardino, L., Maiga, M.A. Bull. World Health Organ. (2003)
- Pertussis in developed countries. Robbins, J.B., Schneerson, R., Trollfors, B. Lancet (2002)
- A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine. Robbins, J.B., Schneerson, R., Gotschlich, E.C. Pediatr. Infect. Dis. J. (2000)
